84 related articles for article (PubMed ID: 10700886)
41. [New evidence of chemotherapy for gastrointestinal cancer].
Boku N
Nihon Shokakibyo Gakkai Zasshi; 2008 Jul; 105(7):987-93. PubMed ID: 18603843
[No Abstract] [Full Text] [Related]
42. Don't multiple drug and other cross resistances in cancer therapy compromise (phase 2) efficacy trials?
Mathé G
Biomed Pharmacother; 1993; 47(9):361-2. PubMed ID: 8068856
[No Abstract] [Full Text] [Related]
43. [Treatment of gastric malignancies using chemotherapy].
Vanovski B; Davcev P; Ilievska M; Serafimovski V; Krstevski M
God Zb Med Fak Skopje; 1977; 23():1007-13. PubMed ID: 614958
[No Abstract] [Full Text] [Related]
44. It's time to rebuild the evidence base.
Moynihan R
BMJ; 2011 May; 342():d3004. PubMed ID: 21613342
[No Abstract] [Full Text] [Related]
45. Chemotherapy of Gastrointestinal Malignancies.
Marsh RW
Cancer Control; 1998 May; 5(3 Suppl 1):28-29. PubMed ID: 10762478
[No Abstract] [Full Text] [Related]
46. Gastrointestinal cancer: Novel promising first-line combination.
Romero D
Nat Rev Clin Oncol; 2018 Mar; 15(3):134. PubMed ID: 29358780
[No Abstract] [Full Text] [Related]
47. Docetaxel and cisplatin in patients with advanced gastric cancer: results of Japanese phase I/II study.
Saitoh S; Sakata Y
Gastric Cancer; 2002; 5 Suppl 1():23-6. PubMed ID: 12772883
[TBL] [Abstract][Full Text] [Related]
48. [Leucovorin and 5-FU for advanced gastrointestinal cancer].
Sasaki T; Maeda Y; Kobayashi T
Gan To Kagaku Ryoho; 1999 Mar; 26(4):440-6. PubMed ID: 10097740
[TBL] [Abstract][Full Text] [Related]
49. [Clinical development of S-1 (TS-1) for advanced gastric cancer].
Wasaburo K; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Mihara S; Nakatani K; Nishimura K; Shimoda T; Azuma M; Katada C; Hanaoka N; Naruke A; Ryu T; Ishido K; Saigenji K
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():57-63. PubMed ID: 16897973
[TBL] [Abstract][Full Text] [Related]
50. [Combination chemotherapy for gastric cancer including LV/5-FU].
Sasaki T; Maeda Y; Kandaba-shi K; Ono M
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1952-6. PubMed ID: 15570919
[TBL] [Abstract][Full Text] [Related]
51. [Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer].
Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Nagaba S; Azuma M; Shimoda T; Nishimura K; Nakatani K; Saigenji K
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1957-61. PubMed ID: 15570920
[TBL] [Abstract][Full Text] [Related]
52. [FOLFIRI regimen for metastatic or recurrent colorectal cancer].
Uemura N; Yamada Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):904-6. PubMed ID: 16835477
[TBL] [Abstract][Full Text] [Related]
53. [Standard chemotherapy for gastrointestinal malignancies based on evidence].
Sasaki T; Maeda Y; Kobayashi T; Okamoto R; Omuro Y; Takada N
Gan To Kagaku Ryoho; 2000 Feb; 27(2):166-76. PubMed ID: 10700886
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
